CAI (STOCKS)
Caris Life Sciences, Inc. Common Stock
$22.472900
+0.212900 (+0.96%)
Prev close: $22.260000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- David Dean Halbert
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $8,539.68M
- Employees
- 1,846
- P/E (TTM)
- 59.79
- P/B (TTM)
- 10.63
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
6
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$0.00 | $0.01 | -0.0101 | -100.00% |
|
Mar 2026 (Q1)
|
$0.00 | $-0.02 | +0.0221 | +100.00% |
|
Dec 2025 (Q4)
|
$0.28 | $0.03 | +0.2481 | +777.74% |
|
Sep 2025 (Q3)
|
$0.08 | $-0.21 | +0.2941 | +138.66% |
Financial Statements
| Revenues | $989.61M |
| Benefits Costs and Expenses | $884.58M |
| Costs And Expenses | $836.34M |
| Nonoperating Income/Loss | -$48.24M |
| Operating Expenses | $836.34M |
| Research and Development | $117.14M |
| Other Operating Expenses | $719.20M |
| Operating Income/Loss | $153.26M |
| Income/Loss From Continuing Operations After Tax | $105.14M |
| Income/Loss From Continuing Operations Before Tax | $105.02M |
| Income Tax Expense/Benefit | -$111.00K |
| Net Income/Loss | $105.14M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $105.14M |
| Net Income/Loss Available To Common Stockholders, Basic | $105.14M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.70 |
| Diluted Earnings Per Share | $1.69 |
| Basic Average Shares | 886,307,639 |
| Diluted Average Shares | 901,420,404 |
| Assets | $1.23B |
| Current Assets | $1.06B |
| Prepaid Expenses | $18.93M |
| Other Current Assets | $1.04B |
| Noncurrent Assets | $171.79M |
| Fixed Assets | $95.72M |
| Other Non-current Assets | $76.08M |
| Liabilities | $637.89M |
| Current Liabilities | $191.44M |
| Accounts Payable | $85.99M |
| Other Current Liabilities | $105.45M |
| Noncurrent Liabilities | $446.45M |
| Long-term Debt | $392.69M |
| Other Non-current Liabilities | $53.76M |
| Equity | $591.73M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $591.73M |
| Liabilities And Equity | $1.23B |
| Net Cash Flow From Operating Activities | $168.56M |
| Net Cash Flow From Operating Activities, Continuing | $168.56M |
| Net Cash Flow From Investing Activities | -$144.72M |
| Net Cash Flow From Investing Activities, Continuing | -$144.72M |
| Net Cash Flow From Financing Activities | -$53.78M |
| Net Cash Flow From Financing Activities, Continuing | -$53.78M |
| Net Cash Flow | -$29.94M |
| Net Cash Flow, Continuing | -$29.94M |
| Comprehensive Income/Loss | $105.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $105.00M |
| Other Comprehensive Income/Loss | $105.00M |
| Other Comprehensive Income/Loss Attributable To Parent | -$153.00K |